chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Mild fatigue after booster dose; This spontaneous case was reported by a nurse and describes the occurrence of FATIGUE (Mild fatigue after booster dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (Mild fatigue after booster dose). At the time of the report, FATIGUE (Mild fatigue after booster dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   On an unknown date, patient received booster dose. The reporter reported no other adverse reactions for her Son In Law. No concomitant medication reported. No treatment medication details reported.   This case was linked to MOD-2022-580291, MOD-2022-580294 (Patient Link).
Started with pain to arm where injection was given followed by fever & body aches. The following day 9/27 2012 c/o just feels weak, "too weak to walk up the stairs".
Abnormal antibody levels greater than 250 U/ml after the first dose; it was itchy; it was intensely red; RASH; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of ANTIBODY TEST ABNORMAL (Abnormal antibody levels greater than 250 U/ml after the first dose), PRURITUS (it was itchy), RASH ERYTHEMATOUS (it was intensely red) and RASH (RASH) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event reported). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and LATANOPROST for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced PRURITUS (it was itchy), RASH ERYTHEMATOUS (it was intensely red) and RASH (RASH). On 15-Feb-2021, the patient experienced ANTIBODY TEST ABNORMAL (Abnormal antibody levels greater than 250 U/ml after the first dose). On 04-Feb-2021, PRURITUS (it was itchy), RASH ERYTHEMATOUS (it was intensely red) and RASH (RASH) outcome was unknown. At the time of the report, ANTIBODY TEST ABNORMAL (Abnormal antibody levels greater than 250 U/ml after the first dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Feb-2021, Antibody test abnormal: abnormal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment were provided.
I had no symptoms the day of the vaccine, Friday. I had a migraine, 100° fever, and body aches most of the day Saturday. Eating food and taking Advil helped for an hour or two. I had a headache most of Sunday.
Information has been received from a pharm. D. concerning a 62 year old male who was vaccinated IM with a 0.5 ml dose of PNEUMOVAX 23 (lot #: 662742/1117X). The patient developed an injection site reaction. The patient had severe erythema from his shoulder to elbow to his elbow. The patient was treated with ATARAX. The reporter did not know if the patient had received PNEUMOVAX in the past. The patient sought medical attention via office visit. Follow-up information has been received from the physician concerning this 62 year old male who on 10-MAR-2009, at 12:50 PM, was vaccinated IM with a dose of PNEUMOVAX (lot #: 662742/1117X). Subsequently, on the same day of vaccination (10-MAR-2009), the patient developed a severe erythema from his shoulder to his elbow. At the time of the report, the patient's status was unknown. This is one of several reports form the same source. No further information is available.
Pt called pharmacy 10/21/20 and complained about soreness and tenderness around injection site. Pt also reported limited strength (e.g. trouble lifting a coffee pot) and limited range of motion.
Previously reported with lot number - VAERS ref# 539288.  High pitch constant sound in both ears (tinnitus) starting evening of shot that occurred on 4/23.  Two visits to ENT confirmed no hearing loss.  Steroid treatment didn?t affect intensity of sound.  Removal of statin for two months and 50% reduction of proton inhibitor did not reduce intensity of sound.
Administered doses from excursion; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Administered doses from excursion) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered doses from excursion). At the time of the report, PRODUCT STORAGE ERROR (Administered doses from excursion) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Med Info Agent:  HCP had an issue at the vaccine clinic where they had a temperature excursion where the highest the vials got was 10.6 degrees Celsius from about 7:30am-3:30pm  Date vials were moved - 11May2021 Quantity of vials affected - 5 vials Lot/batch - 039B21A  Exp - 10/2/21 Patients that were administered doses - 3 on 25May2021 Available to return - Yes  Patients:  PL (Second dose) Male DOB - exact Batch - 039B21A  RL (Second dose) Female > Not pregnant DOB - exact Batch - 039B21A  WW (First dose) Male DOB - exact Batch - 039B21A   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: NNI FU
Patient was inadvertently given COVID-19 bivalent booster by a volunteer vaccinator as his first dose of COVID-19. After the injection, the patient shared that he had never received either dose from the primary series. Patient was provided with information to contact the local health department for further instructions.
Headache; He took Excedrin, before the first dose of the covid vaccine; This is a spontaneous report from a contactable consumer or other non hcp. A 76-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3247), intramuscular, administered in Arm Left on 29Jan2021 (at the age of 76-year-old) as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated that on Friday he received the first shot of the vaccine. He did not had many side effects. Clarified that he had a headache that night and that was about it. Last night on the 10 PM news it was reported that someone had seen on the internet and called the news media to state that people should not take any over the counter aspirin, acetaminophen, or ibuprofen. According to the news they mentioned that it could block some kind of enzyme and may not have the appropriate immune response from the vaccine. He was calling to ask about what he saw on the news, if that was true. About 3 hours before he received the vaccine he had a headache. He did not read anything that said do not take pain medication before taking the vaccine since it could reduce its effectiveness. He was asking if he received the full effect of the vaccine since he took Excedrin 3 hours prior to getting the vaccine. His headache recovered by the time he went to bed. He did not have a fever and he took his temperature with a digital thermometer. He confirms he had no other side effects. This was very vague. People had aches and pains that they take medication for. Nothing says don't do this or that in regard to medications. Other people were probably scratching their heads as well. It does state that participants did have underlying conditions such as hypertension and that they did receive antipyretic medications for post vaccination symptoms, however it doesn't state if they were taking their regular medications, such as blood pressure medications, or not. There was no data available at this time. Referred caller to his HCP and stated that they will have access to clinical data specifically for health care professionals that may help answer questions. The patient underwent lab tests and procedures which included body height: shrunk, body temperature: he did not have a fever. Therapeutic measures were taken as a result of headache (headache) as patient took two over the counter Excedrin which contained aspirin and acetaminophen. The outcome of the event circumstance or information capable of leading to medication error was unknown and for headache it was reported as recovered.  DSU- potential duplicate AE.  Follow-up attempts are completed. No further information is expected.
SIRVA, bone bruise, tendinitis, frozen shoulder.  Severe pain in left shoulder and arm, with shooting pain from left shoulder down to elbow, hand, and fingers on left hand, and numbness in fingertips, by the evening of the day of the vaccination.  Not able to sleep on left side or carry moderately heavy items with left arm.  Within days, unable to raise arm.  About a week later, developed significant lower back pain, likely due to being propped up for GERD and uncomfortable arm sleeping position.  On 4/1/21, began physical therapy for 3 weeks, which helped reduce symptoms somewhat.  Continued PT exercises at home after that.  In September, 2021, was finally able to lift left arm overhead. Varying levels of burning and shooting pain continue to persist in left arm and shoulder, which are aggravated by lifting moderately heavy items or sleeping on left side.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender who on 26-AUG-2013 and on 15-OCT-2014 was vaccinated with a doses of GARDASIL (dose, lot #, expiration date and route were not reported) respectively. No known adverse effects. It was unknown if the patient sought medical attention. Additional information has been requested.
Under arm swollen after booster; This spontaneous case was reported by an other health care professional and describes the occurrence of SWELLING (Under arm swollen after booster) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (Under arm swollen after booster). At the time of the report, SWELLING (Under arm swollen after booster) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter. Treatment information was not provided by the reporter.   Reporter did not allow further contact
PATIENT PASSED OUT WITHIN 1 MINUTE OF RECIEVING VACCINE (BECAME CLAMY, EYES CLOSED, AND WAS SWEATING) AND PHARMACIST HELD HEAD UP, USED WET CLOTH TO WIPE FACE, TOOK PULSE, BLOOD PRESSURE, ELEVATED FEET, AND CALLED 911.  AMBULANCE CAME WITHIN 10 MINUTES OF ADMINISTRATION=CHECKED ALL VITALS AND SAID PATIENT COULD BE TAKEN TO HOSPITAL FOR FURTHER TREATMENT OR WAS OK TO GO. MOM REFUSED MEDICAL TREATMENT AS PATIENT RECOVERED AND HAD EXPECTED REACTION OF SYNCOPE.
Approximately 1.5 hours after receiving the flu shot on Thursday, 10/10/19, I developed severe migraine, nausea, vomiting, drenching sweats, confusion, dizziness, and fever of 101-102. I had to leave work early the next day due to continued nausea and migraine. The migraine and nausea continued, and I went to urgent care on Saturday morning. I was given a Toradol shot with no relief. the migraine lasted until Monday and was downgraded to a dull headache. I have gotten the flu shot for 4 consecutive years and have always gotten sick. This time was unbearable and resulted in lost wages, an urgent care bill and a terrible reaction making it very difficult to function.
This spontaneous prospective pregnancy report has been received from a licensed practical nurse for GARDASIL, a Pregnancy Registry product, concerning a 15 years old female patient, with no drug/reactions/allergies and no pertinent medical history, who received GARDASIL while pregnant. There was no concomitant medications. The patient's history of previous pregnancies and live births is not known. The patient received the first dose of GARDASIL (lot # 668261/1397AA, Exp: 09-APR-2013) on 24-JAN-2012. The second dose of GARDASIL (lot # 668261/1397AA, Exp: 09-APR-2013) on 11-APR-2012, and the third dose on 15-AUG-2012 (Lot # 672721/0101AE, Exp: 10-OCT-2012) (doses and routes not reported). The patient was found to be pregnant on 15-AUG-2012 after she was vaccinated with the third dose of GARDASIL. The patient had a urine pregnancy test on 15-AUG-2012 prior to starting birth control and was found to be pregnant. The patient then stated that her LMP was on 29-APR-2012. EDD would be on 03-FEB-13. The patient was exposed to GARDASIL during trimester 1 and 2. No adverse event reported outside of the pregnancy. No treatment was given. The patient sought medical attention via office contact. Follow up information as received from a licensed practical nurse refers to a 16 years old (currently) female patient with no previous pregnancies who on 26-JAN-2012 at 09:12 am, was vaccinated with of first dose of GARDASIL (lot # 668261/1397AA, Expiration date: 09-APR-2013) in left deltoid. On 11-APR-2012 at 04:07 pm, was vaccinated with of second dose of GARDASIL in left deltoid (lot # 668261/1397AA, Expiration date: 09-APR-2013) and on 15-AUG-2012 at 03:10 pm, was vaccinated of the third dose of GARDASIL in left deltoid (Lot # 672721/0101AE, Expiration date: 10-OCT-2012) (doses not reported). Concomitant medications included ascorbic acid, cholecalciferol, folic acid, magnesium oxide, polysaccharide iron complex, vitamin A, vitamin B complex, vitamin E, SELECT OB, FLAGYL, DIFLUCAN and nitrofurantoin. Subsequently, the patient became pregnant; date of last menstrual period (LMP) was 03-APR-2012 and an estimated delivery date (EDD) of 08-JAN-2013. On 06-SEP-2012, the ultrasound prenatal was performed with a result within normal limits. On an unknown date, the patient experienced urinary tract infection treated with nitrofurantoin (08-OCT-2012); bacterial vaginosis (date unknown) treated with FLAGYL (11-OCT-2012); and yeast infection (date unknown) treated with DIFLUCAN (11-OCT-2012). The patient's outcome for urinary tract infection, yeast infection and bacterial vaginosis were unknown. The relatedness for urinary tract infection, yeast infection and bacterial vaginosis was unknown for GARDASIL. On 03-JAN-2013, the patient delivered a female infant, weighing 6.7; with a length 20 inches. The infant's APGAR scores were 9/9.Upon delivery, the infant was noted to be a normal there were no congenital anomalies healthy newborn. Additional information is not expected.
Child was hospitalized 10/11/17-10/14/17  for vomiting and dehydration due to Enterovirus. Upon discharge, child received influenza vaccine.  She subsequently developed neurological sequelae and was re-admitted to hospital 10/15/17-10/18/17.  CSF was negative for viral etiology, but MRI confirmed encephalitis.
Pt recv vax on 11/23/98; on same day pt exp tender, redness at vax site
PT presents 5 days after administration with pain and moderate limitation of Range of Motion to L arm. Administration site was given too high.
Tachycardia, Numbness, Tingling, Pins & Needles Sensation, Constipation, Pain & Weakness in Arm of injection site, Facial Pain, Dizziness, Fatigue, Chills
Left arm and left side of tongue went numb within minutes of shot. Had some numbing sensation near injection site for 3 days.
Client received HPV #1 vaccine on right upper arm approximately at 5:15pm in company of her mother. Mother during assessment stated she had eaten "goodies" prior to vaccine and was ready to receive her "shot" although she appeared nervous. After informing patient/parent of the benefits of the vaccine and comfort measures, she stated she was ready for "shot". Approximately 2 minutes after administration, patient stated she didn't feel good and sat on her mother's lap. She leaned towards her mother resting her head on mother's chest. "I'll be alright, I just need some time" she added that she felt weak and needed to sit down on chair.  She stood up and with my assistance she proceeded to sit in chair. I questioned mother on her pale color, to which she answered that it was her "normal color", she was always pale. Vital signs taken excluding temperature. P-66, R-12, B/P 108/80.  Patient called on cell phone initiating a conversation. Mother stated she was fine and they needed to go, signing Vaers form that she could no longer stay. Patient left ambulating in company of mother and sister at approximately at 6:00 pm.
pt recvd vax;1nov tingling in feet & toes progressing to paresthesia;weakness & diff walking noted 11nov;& weakness of hands;incontinence of stool & urine noted w/ strain or cough;c/o sore throat & constriction of throat & diff swallowing;
Throughout the day and afternoon patient reports increasing temperature from 99.8F to 101.3F with increasing fatigue and dizziness.
After two weeks of second dose, I started having breathing issues. It felt like upper part of my breathing tube was choked.
Rash and hives, itchy and swollen lymph node on right neck - appeared approximately 24 hours after second dose of vaccine.  Received one shot of steroid and prescribed a 6 day dose of oral steroid.
FEVER, SEVERE CHILLS, HEADACHE, BODY ACHE, SLIGHT NAUSEA. FELT LIKE I HAD THE FLU.
Aches, pains, chills, fever (102), dizziness, weakness, headache. This began about 4 hours after receiving the Flu Vaccine. Still not fully recovered. So far, 24 hours of sleeping, aspirin and no food.
About 4 months after my second injection I began to notice lower pelvic and abdominal pain on the right side. I had an appointment on February 11th, 2022 to inform my doctor of this. After physical examination I had pain and he wanted to order further testing and evaluation the very next day. I then had a catscan, bloodwork, and an ultrasound and it was determined I have an ovarian cyst. Right now I am being monitored every 2 months to evaluate the characteristics of the cyst and decide further action from there.
first dose of Shingrix on 21Jan2020 and has not received the second dose yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 21st January 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional information was provided as follow: The age at vaccination was not applicable for this report. Till the time of reporting patient did not receive 2nd dose of Shingrix vaccine, which led to incomplete course of vaccination. No vaccine data, no other patient's data was reported. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up.
A spontaneous report was received from consumer concerning a female patient (height: 71.0 inches; weight: 150.0 pounds). Patient would get sick 3 times a year during Winter, Spring, Summer. Patient received FLUMIST (intranasal) in 2011 and 2012 and FLUMIST QUADRIVALENT (intranasal) in 2013, 2014 and 2015 so patient do not get the flu. The reporter stated that since taking the FLUMIST, her daughter would get a cold once a year instead of three times a year prior to starting the FLUMIST. She also stated that after the FLUMIST was administered, sniffing would occur because otherwise the vaccine would run out of from the nose after administration. The outcome of the events of cold and after FLUMIST was administered sniffing would occur because otherwise the vaccine would run out from the nose after administration was unknown. The company physician assessed the events of cold and after FLUMIST was administered sniffing would occur because otherwise the vaccine would run out from the nose after administration to be non serious. Corrected report on 08-Nov-2016: Suspect product FLUMIST was added. Dosing regimen was corrected. Associated case id was added. Narrative updated.
Pain numbness and tingling in hands, pain stiffness in all joints.  Weakness in hands.
Meniere's flared up after 1st dose of Shingrix; This case was reported by a physician via call center representative and described the occurrence of meniere's disease aggravated in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included meniere's disease.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced meniere's disease aggravated (serious criteria GSK medically significant). On an unknown date, the outcome of the meniere's disease aggravated was unknown.   It was unknown if the reporter considered the meniere's disease aggravated to be related to Shingrix.  Additional details were provided as follows: The age group was not reported but was selected as adult as per vaccine indication. The physician writing about a patient that received Shingrix. The patient suffers from Menieres and feels that his Menieres flared after the shingrix shot 1. The patient had asked healthcare professional (HCP) to let you all know and if you have heard of other cases. The adverse event (AE) collected. The reporter did not consent to follow-up.
Inflammation of joints, muscle aches, limited mobility that started 1 day after Fluad Quad 2022-2023 vaccine was received.
tightness in chest;h/a base of skull >3-5min p/inj;no rx required;
Petechiae developed on 12/19 on legs and torso and back Took Benadryl although not pruritic.
02/23/2022 - headache, sore throat, face pain, I was having sinus-like symptoms. 02/24/2022 - I went to the Urgent Care. They gave me a COVID-19 test and it was positive. The PA told me to isolate and he prescribed me antiviral medication, Molnupiravir. My headache, sore throat and face pain resolved within 3 or 4 day. I still have some taste issues. I do not think this is an adverse reaction to the vaccine. It is a breakthrough case because I contracted COVID-19 after I received my 2 doses of Pfizer and my Pfizer booster.
Significant pain and motion limitation at vaccination site (upper right arm) -- has lasted for two days at this writing, though seems to gradually be getting better.